#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Crigler-Najjar syndrome Immune thrombocytopenia MELAS syndrome Duchenne muscular dystrophy gene carrier Thrombocytopenia Cardiac failure acute Glomerulonephritis membranoproliferative Neuroblastoma Mantle cell lymphoma stage II Chronic granulomatous disease Chronic myeloid leukaemia Bone marrow disorder Bronchiectasis Extra-osseous Ewing's sarcoma Retinopathy of prematurity More trials…

    Learn about Rare Diseases

    Immunodeficiency congenital – Basic Information Carcinoid syndrome – Treatment Mantle cell lymphoma stage II – Treatment Alexander disease Chondrosarcoma metastatic – Treatment Acquired haemophilia – Life with Disease Skin angiosarcoma – Life with Disease Undifferentiated sarcoma – Trials in Disease Soft tissue sarcoma Osteosarcoma recurrent – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Trifluridine Ptg-Carcik-Cd19 ARTICAINE HYDROCHLORIDE Betibeglogene Autotemcel D-Camphor Rasburicase Human Fibrinogen Rituximab Water For Injection Doxribtimine Holcus Lanatus Pollen Extract Bi 1819479 Oleclumab GS-1720 Cetrorelix Dicloxacillin Loratadine Cocarboxylase Tetrahydrate Sevoflurane Modafinil More therapies…

    Learn about Your Condition

    Chronic disease Hepatotoxicity Bipolar disorder Vesicoureteric reflux Alcohol use disorder Aplasia pure red cell Ehlers-Danlos syndrome Systemic infection Cachexia Eyelid ptosis Brain neoplasm malignant Haemorrhage intracranial Gallbladder cancer Juvenile psoriatic arthritis Complicated appendicitis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Palmoplantar pustulosis

  • A Study Testing How Well Bimekizumab Works and How Safe It Is for Adults with Palmoplantar Pustulosis

    Recruiting

    3 1 1
    Investigated Drugs:
    • Bimekizumab
    Czechia Denmark France Germany Hungary Italy +2

  • Study of Delgocitinib Cream for Adults with Mild to Severe Palmoplantar Pustulosis: A 16-Week Treatment Trial

    Recruiting

    2 1
    Investigated Diseases:
    • Palmoplantar pustulosis
    Germany Poland

  • Study on the Effects of Sonelokimab for Patients with Moderate-to-Severe Palmoplantar Pustulosis

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Palmoplantar pustulosis
    Investigated Drugs:
    • Sonelokimab
    Germany

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!